BG Bunge Global SA
Fats & Oils · NYSE · SEC CIK 1996862 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY55.5%
TTM net income YoY-12.4%
TTM EPS YoY-36.0%
Revenue 3-yr CAGR15.1%
Net income 3-yr CAGR-16.1%
Margins
Gross margin5.1%
Operating margin—
Net margin1.2%
FCF margin-2.8%
EBITDA margin—
Returns
ROE7.2%
ROA2.4%
ROIC (approx.)—
Asset turnover1.95x
Leverage & solvency
Liabilities / assets64.0%
Debt / equity1.03x
Current ratio1.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.82x
Accruals ratio4.4%
Payout ratio47.4%
Capex / revenue1.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $70.33B | $53.11B |
| Cost of revenue | $66.92B | $49.72B |
| Gross profit | $3.41B | $3.39B |
| R&D expense | $28.00M | $30.00M |
| SG&A expense | $2.11B | $1.78B |
| Interest expense | $628.00M | $471.00M |
| Pretax income | $1.13B | $1.52B |
| Income tax | $288.00M | $336.00M |
| Net income | $816.00M | $1.14B |
| EPS (basic) | 4.95 | 8.09 |
| EPS (diluted) | 4.91 | 7.99 |
| Dividends declared per share | 2.80 | 2.72 |
| Weighted avg. shares (diluted) | 166.47M | 142.22M |
| Balance sheet | ||
| Cash & equivalents | $1.14B | $3.33B |
| Short-term investments | $861.00M | $484.00M |
| Receivables | $3.87B | $2.15B |
| Inventory | $13.20B | $6.49B |
| Current assets | $24.39B | $15.96B |
| PP&E, net | $11.68B | $5.25B |
| Goodwill | $3.14B | $453.00M |
| Intangibles | $309.00M | $321.00M |
| Total assets | $44.53B | $24.90B |
| Current liabilities | $15.13B | $7.43B |
| Short-term debt | $5.22B | $1.54B |
| Long-term debt | $8.83B | $4.69B |
| Total debt | $14.05B | $6.24B |
| Total liabilities | $27.11B | $13.95B |
| Shareholders' equity | $15.90B | $9.91B |
| Net debt | $12.92B | $2.91B |
| Cash flow statement | ||
| Operating cash flow | $844.00M | $1.90B |
| Capital expenditure | $1.72B | $1.38B |
| Free cash flow | -$879.00M | $524.00M |
| Investing cash flow | -$5.23B | -$1.11B |
| Financing cash flow | $2.23B | -$90.00M |
| Depreciation & amortization | $703.00M | $468.00M |
| Stock-based compensation | $73.00M | $65.00M |
| Dividends paid | $459.00M | $378.00M |
| Share buybacks | $551.00M | $1.10B |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.